4.5 Letter

Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States

Journal

JAMA INTERNAL MEDICINE
Volume 180, Issue 5, Pages 783-784

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamainternmed.2019.6767

Keywords

-

Ask authors/readers for more resources

This survey study evaluates the early post-US Food and Drug Administration approval experience with an embolic protection device used during transcatheter aortic valve replacement procedures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available